Abstract:Objective To discuss the feasibility of the lung transplantation as an effective treatment for end-stage pulmonary disease domestically. To compare the major issues involving the practice of lung transplantation domestically and overseas.Methods After the foundation of group of lung transplantation in May 2002, we have set up lung transplantation models of porcine. From September. 2002 to August 2005, the 24 LT that were performed included 20 single-lung transplants SLT (83.3%) and 4 Bilateral sequential single lung transplants (BSSLT) (16.7%),among them only one case receive BSSLTx with CPB. Indications for SLT (n=20) , emphysema (n=9),pulmonary fibrosis (n=8),pneumosilicosis(n=1),lymphangioleiomyomatosis(n=1) and ventricular septal defect(VSD) induced Eisenmenger’s syndrome(n=1); for BSSLT (n=4) were bronchiectasis (n=2) and pulmonary emphysema(n=2). 20 SLTs include 11 left single lung transplantation and 9 right lung transplantation. Among them, 2 cases share one same donor’s lung block, one case of contralateral lung transplantation-a left donor lung implanted in the recipient’s right thorax, one cases of simultaneous right single lung transplantation and ventricular septal defect repair. One case receive right single lung transplantation with CPB. Results In-hospital mortality (HM) was 5/24 (20.2%). Among SLT, early death was due to severe infection on the 30th postoperative day in two patient and acute rejection on the 15th postoperative day in other patients ,and another patient died due to pulmonary vein embolism on the 36th day. The patient who is received BSSLTx with CPB died because of acute heart failure. And The patients survived longer than1,2,3 years were 1,2,1 cases respectively. The median overall survival was 10 (1 to 36) months. Conclusions Our LT program shows similar results to those reported by the International Society for Heart and Lung Transplantation for developed countries. A rapid development era of lung transplantation is emerging in China. The key of successful operation depends on the establishment of group of lung transplantation and cooperation of multi-department. Ischemic-reperfusion injury, acute-rejection and infection are the major reasons of deaths shortly after the operations.

Outcomes of single lung transplantation in 23 patients with end-stage chronic obstructive pulmonary disease:a single center 8-year experience

Lung transplantation in 42 cases:an 8-year experience in a single center

Mid-term results after lung transplantation in 23 consecutive recipients at a single center

Clinical Analysis of 100 Cases of Lung Transplantation for End-Stage Pulmonary Diseases

Surgical techniques and perioperative management of lung transplantation:a report of 3 cases

Initial Experience of Lung Transplantation at A Single Center in China

Single Lung Transplantation for Severe Pulmonary Emphysema

Three Year’s Experience of Lung Transplantation for End-stage Pulmonary Disease.

Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis

Lung transplantation for COPD/pulmonary emphysema

Lung transplantation for end-stage silicosis.

Risk factors for the long-term survival of patients after lung transplantation

Analysis of clinical outcomes of bilateral lung transplantation with simultaneous lung volume reduction surgery on end-stage lung disease

Lung Transplantation In China Between 2015 And 2018

[Single-lung transplantation for end-stage pulmonary parenchymal diseases with pulmonary hypertension]

[The operative technique selection of lung transplantation for end-stage emphysema]

Outcomes of single vs double lung retransplantation in patients with cystic fibrosis

Lung transplantation for bronchiolitis obliterans after hematopoietic stem cell transplantation: a retrospective single-center study

Complications and survival in COPD patients undergoing lung transplantation

Perioperative management of lung transplant recipients at a single center: analysis of 105 cases

Lung Transplantation for End-Stage Emphysema:A Report of 19 Cases